15 results in Exploration of Drug Science
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Molecular drivers of ageing and emerging longevity therapies
Magaa Lakshmi Dhinakaran ... Dinesh Kumar Srinivasan
Published: February 26, 2026 Explor Drug Sci. 2026;4:1008152
46 9 0
Open Access Review
Phytochemical profiles and therapeutic applications of selected medicinal plants: an evidence-based narrative review
Saurabh Dilip Bhandare, Sarika Shivaji Malode
Published: February 25, 2026 Explor Drug Sci. 2026;4:1008151
69 12 0
Open Access Original Article
Peptide treatment of human plasma disrupts metabolic and age-related pathologies via heat shock protein 70
Timothy J. Cunningham
Published: February 24, 2026 Explor Drug Sci. 2026;4:1008150
This article belongs to the special issue Peptide Science Without Borders: Novel Insights for Drug Discovery
99 5 0
Open Access Review
Exploring s-triazine derivatives as anticancer agents
Anamika Sharma ... Ayman El-Faham
Published: February 11, 2026 Explor Drug Sci. 2026;4:1008149
This article belongs to the special issue The Role of Triazine Scaffolds in Modern Drug Development
506 32 0
Open Access Original Article
Prophylactic metoclopramide for preventing opioid-induced nausea and vomiting in cancer pain: a retrospective cohort study
Xianglian Ma ... Jiuda Zhao
Published: February 02, 2026 Explor Drug Sci. 2026;4:1008148
521 18 0
Open Access Review
Vinyl sulfones: selective and tunable covalent warheads against challenging enzyme targets
Ronald E. Viola
Published: February 01, 2026 Explor Drug Sci. 2026;4:1008147
This article belongs to the special issue The Rise of Targeted Covalent Inhibitors in Drug Discovery
702 29 0
Open Access Case Report
A case series of CBT-inspired behavioral and medical interventions for uncontrolled type 2 diabetes
Ahmed Nouri, Bassam Abu Madi
Published: February 01, 2026 Explor Drug Sci. 2026;4:1008146
627 18 0
Open Access Original Article
Small molecule and fragment-based phenotypic screening for novel building blocks with antimycobacterial activity
Monika I. Konaklieva ... Balbina J. Plotkin
Published: February 01, 2026 Explor Drug Sci. 2026;4:1008145
This article belongs to the special issue Discovery and development of new antibacterial compounds
357 16 0
Open Access Systematic Review
Harnessing nanomaterials to overcome antimicrobial resistance in Gram-positive bacteria: a systematic review
Olalekan John Okesanya ... Don Eliseo Lucero-Prisno III
Published: January 28, 2026 Explor Drug Sci. 2026;4:1008144
850 27 0
Open Access Systematic Review
Janus-faced role of anti-infective drugs: a revisit through the lens of vascular ageing
Ceaser Wankumbu Silumbwe ... Kebby Mazyamuna
Published: January 14, 2026 Explor Drug Sci. 2026;4:1008143
850 26 0
Open Access Original Article
Multiscale computational profiling of a promising carbapenemase inhibitor: from binding dynamics to quantum reactivity
Ayuba Olanrewaju Mustapha ... Yusuf Oloruntoyin Ayipo
Published: January 09, 2026 Explor Drug Sci. 2026;4:1008140
This article belongs to the special issue Discovery and development of new antibacterial compounds
565 16 0
Open Access Systematic Review
Targeted therapeutic management of diabetes using phytoconstituents: molecular mechanisms, evidence map (2015–2025), and translational outlook
Chizurum Philip Ikegbuna ... Mmesoma Ruth Ikegbuna
Published: January 07, 2026 Explor Drug Sci. 2026;4:1008139
1212 41 0
Open Access Original Article
Novel antimicrobial efficacy on inert surfaces of chlorhexidine-silver nanoparticle veterinary formulation
Daniel Buldain ... Laura Marchetti
Published: January 05, 2026 Explor Drug Sci. 2026;4:1008138
This article belongs to the special issue Discovery and development of new antibacterial compounds
786 30 0